Topic · Sarcoma Diagnosis and Treatment
Most cited papers in Sarcoma Diagnosis and Treatment
What are the most cited papers in Sarcoma Diagnosis and Treatment?
The most cited paper in Sarcoma Diagnosis and Treatment is "International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes" (Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al., 1997), with 4,480 citations. Next come "Case report 3" (4,090) and "A System for the Surgical Staging of Musculoskeletal Sarcoma" (2,513).
Showing 50 of 100 papers. Every paper with more than 834 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood | 15 Mar 1997 | 4,480 |
| 2 | Case report 3 Murray K. Dalinka, R. E. Brennan, Arthur S. Patchefsky · Skeletal Radiology | 1976 | 4,090 |
| 3 | A System for the Surgical Staging of Musculoskeletal Sarcoma William F. Enneking, Suzanne S. Spanier, MARK A. GOODMAN · Clinical Orthopaedics and Related Research | Nov 1980 | 2,513 |
| 4 | Hypoxia in cancer: significance and impact on clinical outcome Peter W. Vaupel, Arnulf Mayer · Cancer and Metastasis Reviews | 18 Apr 2007 | 2,256 |
| 5 | A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt et al. · Clinical Orthopaedics and Related Research | 1993 | 2,226 |
| 6 | Osteosarcoma incidence and survival rates from 1973 to 2004 Lisa Mirabello, Rebecca J. Troisi, Sharon A. Savage · Cancer | 5 Feb 2009 | 2,215 |
| 7 | Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial Winette T.A. van der Graaf et al. · The Lancet | May 2012 | 2,123 |
| 8 | B cells are associated with survival and immunotherapy response in sarcoma Florent Petitprez et al. · Nature | 15 Jan 2020 | 2,007 |
| 9 | Amplification of a gene encoding a p53-associated protein in human sarcomas Jonathan D. Oliner, Kenneth W. Kinzler, Paul S. Meltzer et al. · Nature | Jul 1992 | 1,969 |
| 10 | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Olivier Delattre, Jessica Zucman‐Rossi, Béatrice Plougastel-Douglas et al. · Nature | Sep 1992 | 1,928 |
| 11 | Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols Stefan S. Bielack, Beate Kempf‐Bielack, G. Delling et al. · Journal of Clinical Oncology | Feb 2002 | 1,872 |
| 12 | The Epidemiology of Osteosarcoma Giulia Ottaviani, Norman Jaffe · Cancer treatment and research | 2009 | 1,825 |
| 13 | A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System Craig Gerrand, Kenneth Samora Rankin | 7 Dec 2013 | 1,797 |
| 14 | Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology | 28 Mar 2018 | 1,636 |
| 15 | Osteosarcoma: Current Treatment and a Collaborative Pathway to Success Michael S. Isakoff, Stefan S. Bielack, Paul S. Meltzer et al. · Journal of Clinical Oncology | 24 Aug 2015 | 1,633 |
| 16 | Reflecting on 25 years with MYC Natalie Meyer, Linda Z. Penn · Nature reviews. Cancer | 24 Nov 2008 | 1,633 |
| 17 | von Hippel-Lindau disease Russell R. Lonser, Gladys M. Glenn, McClellan M. Walther et al. · The Lancet | Jun 2003 | 1,616 |
| 18 | Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial Brian P O'Sullivan, Aileen M. Davis, ROBERT E. TURCOTTE et al. · The Lancet | Jun 2002 | 1,613 |
| 19 | Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Jin Yang, Alfred E. Chang, A Baker et al. · Journal of Clinical Oncology | 1998 | 1,541 |
| 20 | Clinical translation of angiogenesis inhibitors Robert S. Kerbel, Judah Folkman · Nature reviews. Cancer | Oct 2002 | 1,524 |
| 21 | Malignant fibrous histiocytoma.An Analysis of 200 Cases Sharon Whelan Weiss, Franz M. Enzinger · Cancer | Jun 1978 | 1,506 |
| 22 | Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients Margaret R. Wallace, Douglas A. Marchuk, Lone B. Andersen et al. · Science | 13 Jul 1990 | 1,488 |
| 23 | Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial Hussein A. Tawbi et al. · The Lancet Oncology | 10 Oct 2017 | 1,479 |
| 24 | Gastrointestinal Stromal Tumors: Review on Morphology, Molecular Pathology, Prognosis, and Differential Diagnosis Markku Miettinen, Jerzy P. Lasota · Archives of Pathology & Laboratory Medicine | Oct 2006 | 1,467 |
| 25 | Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 Guy Armand Rouleau et al. · Nature | Jun 1993 | 1,427 |
| 26 | Characteristics and Significance of the Pre-metastatic Niche Yang Liu, Xuetao Cao · Cancer Cell | Nov 2016 | 1,387 |
| 27 | Localized Benign and Malignant Fibrous Tumors of the Pleura Douglas M. England, Liselotte Hochholzer, Michael J. McCarthy · The American Journal of Surgical Pathology | Aug 1989 | 1,373 |
| 28 | The Treatment of Soft-tissue Sarcomas of the Extremities Steven A. Rosenberg, Joel E. Tepper, ELI J. GLATSTEIN et al. · Annals of Surgery | Sep 1982 | 1,359 |
| 29 | Von Recklinghausen Neurofibromatosis Vincent Michael Riccardi · New England Journal of Medicine | 31 Dec 1981 | 1,359 |
| 30 | Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone Holcombe E. Grier, Mark Krailo, Nancy J. Tarbell et al. · New England Journal of Medicine | 19 Feb 2003 | 1,348 |
| 31 | Translational biology of osteosarcoma Maya Kansara, Michele W.L. Teng, Mark John Smyth et al. · Nature reviews. Cancer | 16 Oct 2014 | 1,341 |
| 32 | Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system Monique Trojani, G Contesso, Jean‐Michel Coindre et al. · International Journal of Cancer | 15 Jan 1984 | 1,327 |
| 33 | RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES Shunmugam Govender, Cristina Csimma, Harry K. Genant et al. · Journal of Bone and Joint Surgery | Dec 2002 | 1,293 |
| 34 | Osteosarcoma treatment – Where do we stand? A state of the art review Anja Luetke, Paul A. Meyers, Ian J. Lewis et al. · Cancer Treatment Reviews | 27 Nov 2013 | 1,285 |
| 35 | Tumors as Organs: Complex Tissues that Interface with the Entire Organism Mikala Egeblad, Elizabeth S. Nakasone, Zena Werb · Developmental Cell | Jun 2010 | 1,275 |
| 36 | Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study Allan T. van Oosterom, Ian Robert Judson, Jaap Verweij et al. · The Lancet | Oct 2001 | 1,272 |
| 37 | Applications and limitations of radiomics Stephen S. F. Yip, Hugo J.W.L. Aerts · Physics in Medicine and Biology | 7 Jun 2016 | 1,263 |
| 38 | Gastrointestinal Stromal Tumors of the Stomach Markku Miettinen, Leslie H. Sobin, Jerzy P. Lasota · The American Journal of Surgical Pathology | 17 Dec 2004 | 1,263 |
| 39 | Multistep Nature of Metastatic Inefficiency Keith J. Luzzi, Ian C. MacDonald, Eric E. Schmidt et al. · American Journal Of Pathology | Sep 1998 | 1,263 |
| 40 | Clinical guidelines: Developing guidelines P. G Shekelle, Steven H. Woolf, Marriner S. Eccles et al. · BMJ | 27 Feb 1999 | 1,240 |
| 41 | Biology of Gastrointestinal Stromal Tumors Christopher L. Corless, Jonathan Alfred Fletcher, Michael Charles Heinrich · Journal of Clinical Oncology | 13 Sep 2004 | 1,230 |
| 42 | Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. Peter W. T. Pisters, Denis H. Y. Leung, James M. Woodruff et al. · Journal of Clinical Oncology | May 1996 | 1,228 |
| 43 | Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial Ian Robert Judson, Jaap Verweij, Hans A. J. Gelderblom et al. · The Lancet Oncology | 5 Mar 2014 | 1,195 |
| 44 | Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. David M. Brizel, Sean P. Scully, John M. Harrelson et al. · PubMed | Mar 1996 | 1,194 |
| 45 | Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology Margaret von Mehren et al. · Journal of the National Comprehensive Cancer Network | Jul 2022 | 1,188 |
| 46 | Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex Lawrence Steven Kirschner, J. Aidan Carney, Svetlana Pack et al. · Nature Genetics | Sep 2000 | 1,164 |
| 47 | Fibroblasts, myofibroblasts, and wound contraction Frederick Grinnell · The Journal of Cell Biology | 15 Feb 1994 | 1,158 |
| 48 | The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives Marta Sbaraglia, Elena Bellan, Angelo Paolo Dei Tos · Pathologica | Nov 2020 | 1,135 |
| 49 | The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity J. Aidan Carney, Hymie Gordon, Paul C. Carpenter et al. · Medicine | Jul 1985 | 1,129 |
| 50 | The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts Olivier Delattre, Jessica Zucman‐Rossi, Thomas Melot et al. · New England Journal of Medicine | 4 Aug 1994 | 1,115 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.